Pregnancy is an incredible journey, but for women with coeliac disease it is still an ongoing challenge. Properly managing a nutritionally balanced and strict gluten-free diet during the journey to motherhood continues to be a difficult task. Current guidelines (1) do not provide recommendations for determining the appropriate energy intake for coeliac women during pregnancy.
For Dr. Schär, global leader in gluten-free and special nutrition, performance was positive in all regions, with the United Kingdom remaining one of the top markets. The South Tyrolean company, led by Hannes Berger, consolidates its leadership and continues its growth strategy, aiming for global sales of €600 million by 2024.
Dr. Schär, the leading Italian company for gluten-free and special nutrition, closed the 2024 financial year with a global turnover of GBP 524 million, up 11% on the previous year. Performance was positive in all regions, with around 70% of revenue generated by the foreign subsidiaries. Italy, Germany and the USA are the biggest markets. Key markets also include the United Kingdom, where Dr. Schär has a head office in Warrington and a gluten free bakery in Glasgow. The year-end results confirm the company’s financial strength and consolidate its leadership, also thanks to a significant investment of GBP 38 million in innovation and expansion. The double-digit growth is driven by the Schär brand and supported by a strategy focused on internationalisation and strengthening local production, key elements of a successful model.
Dr. Schär, global leader in gluten-free and special nutrition, is further reinforcing its commitment to sustainability with the development of new packaging for the Schär Wholesome bread range, its most popular product on the global market. As a result, the company will cut plastic in Schär packs by 15%.